4//SEC Filing
Bealer Jennifer 4
Accession 0001179110-21-010021
CIK 0001551306other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 8:57 PM ET
Size
22.8 KB
Accession
0001179110-21-010021
Insider Transaction Report
Form 4
Progyny, Inc.PGNY
Bealer Jennifer
EVP, General Counsel
Transactions
- Sale
Common Stock
2021-11-05$68.06/sh−211$14,360→ 61,541 total - Award
Common Stock
2021-11-08+30,000→ 91,541 total - Sale
Common Stock
2021-11-08$65.66/sh−11,499$755,024→ 76,579 total - Sale
Common Stock
2021-11-05$66.28/sh−2,157$142,959→ 62,733 total - Sale
Common Stock
2021-11-08$64.61/sh−3,463$223,727→ 88,078 total - Sale
Common Stock
2021-11-08$66.55/sh−6,963$463,416→ 69,616 total - Sale
Common Stock
2021-11-08$67.17/sh−200$13,433→ 69,416 total - Award
Employee Stock Option (Right to Buy)
2021-11-08+115,000→ 115,000 totalExercise: $66.66Exp: 2031-11-07→ Common Stock (115,000 underlying) - Sale
Common Stock
2021-11-05$65.10/sh−1,700$110,677→ 64,890 total - Sale
Common Stock
2021-11-05$64.66/sh−5,041$325,936→ 66,590 total - Sale
Common Stock
2021-11-05$67.09/sh−981$65,819→ 61,752 total
Footnotes (12)
- [F1]Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 28, 2021.
- [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.15 to $67.12, inclusive.
- [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.16 to $67.17, inclusive.
- [F12]One-fourth (1/4th) of the shares subject to the option will vest November 8, 2022 and the remainder of the shares will vest in equal quarterly installments thereafter through November 8, 2025, subject to the Reporting Person continuing to provide service through each such date.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.51 to $65.47, inclusive.
- [F3]The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (4), (5), (6), (8), (9), (10) and (11).
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.59 to $66.55, inclusive.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.60 to $67.51, inclusive.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.79 to $68.32, inclusive.
- [F7]Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. One-fourth (1/4th) of the RSUs will vest on November 8, 2022 and the remainder of the shares will vest in equal quarterly installments thereafter through November 8, 2025, subject to the Reporting Person continuing to provide service through each such date.
- [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.11 to $65.04, inclusive.
- [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.13 to $66.12, inclusive.
Documents
Issuer
Progyny, Inc.
CIK 0001551306
Entity typeother
Related Parties
1- filerCIK 0001789513
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 8:57 PM ET
- Size
- 22.8 KB